Previous 10 | Next 10 |
Gainers: Acorda Therapeutics (ACOR) +45%, NuCana (NCNA) +26%, Synlogic (SYBX) +24%, Evoke Pharma (EVOK) +23%, Tiziana Life Sciences (TLSA) +14%.Losers: Zomedica (ZOM) -26%, Forward Pharma (FWP) -15%, Provention Bio (PRVB) -14%, Acutu...
Acorda Therapeutics (ACOR) jumps 65% premarket after entering into an agreement for the sale of its Inbrija manufacturing operations in Chelsea, Massachusetts to Catalent (CTLT) for $80M in cash.In connection with the sale, both the companies have entered into a global supply a...
Acorda Therapeutics (ACOR) +54% after announcing agreement for sale of manufacturing operations and long-term global supply agreement.Summit Midstream Partners (SMLP) +45% after winning FERC construction OK.WiMi Hologram Cloud (WIMI) +38% on obtaining a patent for a 3D holograp...
$80 million up-front payment will substantially increase cash balance Sale, restructuring and other operating expense reductions will reduce annual operating expenses by approximately $40 million Total 2021 non-GAAP operating expense guidance expected to be $130-$140 million ...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present at the 39 th Annual J.P. Morgan Health Care Conference on Thursday, January 14, at 5:20 PM ET. A live audio webcast of the presentation can be accessed under ...
Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the January 11 th -14 th H.C. Wainwright BIOCONNECT Virtual Conference. An audio webcast of the presentation can be accessed under “Investor...
Gainers: Bionano Genomics (BNGO) +90%, Ocugen OCGN +72%, ViewRay VRAY +26%, Pandion Therapeutics PAND +25%, EyePoint Pharmaceuticals EYPT +21%.Losers: Calithera Biosciences CALA -41%, Acorda Therapeutics (ACOR) -16%, Sigilon The...
To satisfy compliance with Nasdaq's $1 minimum bid price, Acorda Therapeutics (ACOR) has completed its 1-for-6 reverse stock split.The shares will start trading on split-adjusted basis from the market open on Jan.4, 2021. Stock down 1.03% AH.Now Read: COVID-19 vaccine make...
Common Stock to Begin Trading on a Split-Adjusted Basis upon Market Open on January 4, 2021 Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has completed the previously announced 1-for-6 reverse stock split of its outstanding and authorized shares of common ...
Can These Biotech Penny Stocks Continue to Climb Amidst a Potential Covid Vaccine? Biotech penny stocks have seen increased popularity in the past few months due to Covid. On Monday, November 9th, Pfizer Inc. ( PFE Stock Report ) announced that its vaccine candidate is more than...
News, Short Squeeze, Breakout and More Instantly...
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 28.8% to $0.0515 on volume of 62,068,605 shares Laser Photonics Corporation (LASE) rose 172.7% to $3.9 on volume of 54,588,758 shares WiSA Technologies Inc. (WISA) fell 6.1% to $0.0217 on volume of 2...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announc...